SynAct Pharma AB (FRA:8F8)
1.600
+0.008 (0.50%)
At close: Mar 27, 2026
14.70% (1Y)
| Market Cap | 92.35M +34.5% |
| Revenue (ttm) | n/a |
| Net Income | -10.24M |
| EPS | -0.20 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 17.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 1.562 |
| Previous Close | 1.592 |
| Day's Range | 1.548 - 1.600 |
| 52-Week Range | 1.220 - 2.320 |
| Beta | n/a |
| RSI | 40.46 |
| Earnings Date | Apr 15, 2026 |